nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Quinapril—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Quinapril—Infection—Teniposide—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Quinapril—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Quinapril—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Quinapril—Tachycardia—Teniposide—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Quinapril—Malaise—Fludarabine—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Quinapril—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Quinapril—Pruritus—Mechlorethamine—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Quinapril—Cough—Fludarabine—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Quinapril—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Quinapril—Arthralgia—Fludarabine—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Quinapril—Myalgia—Fludarabine—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Quinapril—Discomfort—Fludarabine—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Quinapril—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Quinapril—Dyspnoea—Teniposide—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Quinapril—Depression—Carmustine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Quinapril—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Quinapril—Oedema—Fludarabine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Quinapril—Infection—Fludarabine—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Quinapril—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Quinapril—Renal failure—Carmustine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Quinapril—Vomiting—Mechlorethamine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Quinapril—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Quinapril—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Quinapril—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Quinapril—Urinary tract infection—Carmustine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Quinapril—Rash—Mechlorethamine—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Quinapril—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Quinapril—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Quinapril—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Quinapril—Depression—Vincristine—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Quinapril—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Quinapril—Myocardial infarction—Vincristine—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Quinapril—Feeling abnormal—Teniposide—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Quinapril—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Quinapril—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Quinapril—Renal failure—Mitoxantrone—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Quinapril—Nausea—Mechlorethamine—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Quinapril—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Quinapril—Alopecia—Bleomycin—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Quinapril—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Quinapril—Abdominal pain—Teniposide—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Quinapril—Paraesthesia—Fludarabine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Quinapril—Dyspnoea—Fludarabine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Quinapril—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Quinapril—Dyspepsia—Fludarabine—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Quinapril—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Quinapril—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Quinapril—Fatigue—Fludarabine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Quinapril—Constipation—Fludarabine—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Quinapril—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Quinapril—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Quinapril—Urethral disorder—Vincristine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Quinapril—Eye disorder—Carmustine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Quinapril—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Quinapril—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Quinapril—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Quinapril—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Quinapril—Asthenia—Teniposide—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Quinapril—Malaise—Bleomycin—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Quinapril—Pruritus—Teniposide—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Quinapril—Arrhythmia—Carmustine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Quinapril—Cardiac disorder—Vincristine—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Quinapril—Alopecia—Carmustine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Quinapril—Mental disorder—Carmustine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Quinapril—Cough—Bleomycin—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Quinapril—Angiopathy—Vincristine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Quinapril—Diarrhoea—Teniposide—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Quinapril—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Quinapril—Chest pain—Bleomycin—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Quinapril—Myalgia—Bleomycin—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Quinapril—Alopecia—Vincristine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Quinapril—Back pain—Carmustine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Quinapril—Discomfort—Bleomycin—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Quinapril—Mental disorder—Vincristine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Quinapril—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Quinapril—Alopecia—Mitoxantrone—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Quinapril—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Quinapril—Oedema—Bleomycin—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Quinapril—Infection—Bleomycin—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Quinapril—Back pain—Vincristine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Quinapril—Vomiting—Teniposide—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Quinapril—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Quinapril—Asthenia—Fludarabine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Quinapril—Rash—Teniposide—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Quinapril—Dermatitis—Teniposide—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Quinapril—Headache—Teniposide—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Quinapril—Pruritus—Fludarabine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Quinapril—Back pain—Mitoxantrone—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Quinapril—Diarrhoea—Fludarabine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Quinapril—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Quinapril—Nausea—Teniposide—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Quinapril—Vertigo—Vincristine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Quinapril—Myalgia—Carmustine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Quinapril—Chest pain—Carmustine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Quinapril—Paraesthesia—Bleomycin—lymphatic system cancer	0.003	0.003	CcSEcCtD
Quinapril—Malaise—Mitoxantrone—lymphatic system cancer	0.003	0.003	CcSEcCtD
Quinapril—Dyspnoea—Bleomycin—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Quinapril—Renal failure acute—Methotrexate—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Quinapril—Oedema—Carmustine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Quinapril—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Quinapril—Myalgia—Vincristine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Quinapril—Cough—Mitoxantrone—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Quinapril—Infection—Carmustine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Quinapril—Vomiting—Fludarabine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Quinapril—Rash—Fludarabine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Quinapril—Dermatitis—Fludarabine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Quinapril—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Quinapril—Headache—Fludarabine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Quinapril—Tachycardia—Carmustine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Quinapril—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Quinapril—Myalgia—Mitoxantrone—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Quinapril—Chest pain—Mitoxantrone—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Quinapril—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Quinapril—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Quinapril—Discomfort—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Quinapril—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Quinapril—Oedema—Vincristine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Quinapril—Infection—Vincristine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Quinapril—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Quinapril—Nervous system disorder—Vincristine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Quinapril—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Quinapril—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Quinapril—Oedema—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Quinapril—Nausea—Fludarabine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Quinapril—Infection—Mitoxantrone—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Quinapril—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Quinapril—Shock—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Quinapril—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Quinapril—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Quinapril—Insomnia—Carmustine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Quinapril—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Quinapril—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Quinapril—Paraesthesia—Carmustine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Quinapril—Dyspnoea—Carmustine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Quinapril—Somnolence—Carmustine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Quinapril—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Quinapril—Insomnia—Vincristine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Quinapril—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Quinapril—Paraesthesia—Vincristine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Quinapril—Constipation—Carmustine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Quinapril—Breast disorder—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Quinapril—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Quinapril—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Quinapril—Somnolence—Mitoxantrone—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Quinapril—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Quinapril—Feeling abnormal—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Quinapril—Fatigue—Vincristine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Quinapril—Asthenia—Bleomycin—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Quinapril—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Quinapril—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Quinapril—Constipation—Vincristine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Quinapril—Pruritus—Bleomycin—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Quinapril—Fatigue—Mitoxantrone—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Quinapril—Pancreatitis—Methotrexate—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Quinapril—Constipation—Mitoxantrone—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Quinapril—Abdominal pain—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Quinapril—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Quinapril—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Quinapril—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Quinapril—Abdominal pain—Vincristine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Quinapril—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Quinapril—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Quinapril—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Quinapril—Vomiting—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Quinapril—Infestation NOS—Methotrexate—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Quinapril—Infestation—Methotrexate—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Quinapril—Depression—Methotrexate—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Quinapril—Rash—Bleomycin—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Quinapril—Dermatitis—Bleomycin—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Quinapril—Asthenia—Carmustine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Quinapril—Renal failure—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Quinapril—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Quinapril—Asthenia—Vincristine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Quinapril—Diarrhoea—Carmustine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Quinapril—Nausea—Bleomycin—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Quinapril—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Quinapril—Asthenia—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Quinapril—Dizziness—Carmustine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Quinapril—Diarrhoea—Vincristine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Quinapril—Hepatitis—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Quinapril—Pharyngitis—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Quinapril—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Quinapril—Urethral disorder—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Quinapril—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Quinapril—Vomiting—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Quinapril—Dizziness—Vincristine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Quinapril—Rash—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Quinapril—Dermatitis—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Quinapril—Headache—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Quinapril—Eye disorder—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Quinapril—Vomiting—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Quinapril—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Quinapril—Rash—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Quinapril—Dermatitis—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Quinapril—Headache—Vincristine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Quinapril—Nausea—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Quinapril—Angiopathy—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Quinapril—Vomiting—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Quinapril—Immune system disorder—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Quinapril—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Quinapril—Rash—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Quinapril—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Quinapril—Headache—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Quinapril—Alopecia—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Quinapril—Mental disorder—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Quinapril—Nausea—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Quinapril—Nausea—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Quinapril—Back pain—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Quinapril—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Quinapril—Malaise—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Quinapril—Vertigo—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Quinapril—Cough—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Quinapril—Arthralgia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Quinapril—Chest pain—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Quinapril—Myalgia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Quinapril—Discomfort—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Quinapril—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Quinapril—Infection—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Quinapril—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Quinapril—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Quinapril—Skin disorder—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Quinapril—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Quinapril—Insomnia—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Quinapril—Paraesthesia—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Quinapril—Dyspnoea—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Quinapril—Somnolence—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Quinapril—Dyspepsia—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Quinapril—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Quinapril—Fatigue—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Quinapril—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Quinapril—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Quinapril—Abdominal pain—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Quinapril—Asthenia—Methotrexate—lymphatic system cancer	0.00097	0.00097	CcSEcCtD
Quinapril—Pruritus—Methotrexate—lymphatic system cancer	0.000957	0.000957	CcSEcCtD
Quinapril—Diarrhoea—Methotrexate—lymphatic system cancer	0.000925	0.000925	CcSEcCtD
Quinapril—Dizziness—Methotrexate—lymphatic system cancer	0.000894	0.000894	CcSEcCtD
Quinapril—Vomiting—Methotrexate—lymphatic system cancer	0.00086	0.00086	CcSEcCtD
Quinapril—Rash—Methotrexate—lymphatic system cancer	0.000853	0.000853	CcSEcCtD
Quinapril—Dermatitis—Methotrexate—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Quinapril—Headache—Methotrexate—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Quinapril—Nausea—Methotrexate—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
